We offer you the tests and solutions to protect your people, your customers and your business.
ALPHA PROLIPSIS offers your team or your customers the answers to their two most pressing COVID-19 questions:
- Do I have COVID-19 now? – ALPHA PROLIPSIS’ PCR test
- Have I been exposed to SARS-CoV-2? – ALPHA PROLIPSIS ’ Serology test
By offering both tests on your terms, ALPHA PROLIPSIS can help protect your people, your customers and your business in the post-COVID-19 world.
WHICH TEST IS RIGHT FOR YOU?
Tests are only useful if they fit the clinical context of your business’ employees.
The right questions
We provide you with a simple questionnaire to help you identify who to test. Questions are focused on the past and current symptoms.
The right answers
Laboratory analysis gives you an essential portrait of past and current infection across your organization. Our range of programmes offer one-off tests for those looking for a current snapshot, or enduring regimens for businesses in need of ongoing monitoring. PCR and Serology testing both play an important part in most scenarios
OUR MEDICAL QUESTIONNAIRE:
Our experts have designed a medical questionnaire to allow you to identify current and past relevant symptoms and triggers such as fever, cough and shortness of breath.
Our accredited labs are at the forefront of COVID-19-diagnostics innovation; partnering with us gives you access to the most current testing techniques.
Possible Options for Results | SARS-COV-2 RNA Test Result Status
“Negative” shall mean that no SARS-COV-2 RNA (from the genetic regions analysed) was detected in the sample tested. The patient will receive a result certificate with the result stating “Negative” with the sample received date and time and the report date.
“Positive” shall mean that SARS-COV-2 RNA (from the genetic regions analysed) was detected in the sample tested. The patient will receive a result certificate with the result stating “Positive” with the samples received date and time and the report date.
“Invalid” means that internal sample controls failure occurred due to PCR inhibition caused by factors like inhibitors present on the sample or other sample issues. In the event of such result, sampling must be repeated in order to perform the test in a new sample. The patient will not receive a result certificate and will be required to apply for a new test.
“Inconclusive” means that one or more genes are amplified in late cycles (usually above ct 35), meaning low viral loads (due to recovery period after disease or disease incubation period). Late cycles can also be produced by polymerase amplification errors. This type of result must be interpreted with the patient clinical information and the test repeated if relevant. The relevant patient will not receive a result certificate and will be required to apply for a new test.
“Repeat Sample” means that issues related to sample integrity have occurred. The relevant patient will be required a re-testing at no additional charges. Patient will be requested to schedule a re-testing appointment once “Repeat Sample” has been uploaded by the relevant laboratory.
Since new and novel strains of the SARS-COV-2 (Corona-Virus) and new virus mutations, including newly emerged variants of the Corona-Virus have emerged during the recent weeks, ALPHA PROLIPSIS is unable to guarantee the above test results in each specific case, in particular, shall the patient carry one of the abovementioned novel strains, virus mutations or newly emerged variants of the Corona-Virus. The patient hereby confirm that this is known to his/her. While ALPHA PROLIPSIS has implemented several measures in this regard, ALPHA PROLIPSIS shall not be liable in case of incorrect or imprecise results or false positives in case these have been caused by novel strains, virus mutations or newly emerged variants of the Corona-Virus.